A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors

Bioorganic & Medicinal Chemistry
Nicolas LevoinRené Grée

Abstract

Inhibition of Bcl-2 family protein-protein interactions (PPI) is a very promising direction in cancer chemotherapy. Hence over the last decade, many medicinal chemistry studies endeavoured to discover drug candidates, and a wealth of chemical scaffolds with striking chemical diversity was reported as Bcl-xL inhibitors. This raises the question of whether all these molecules could occupy a unique binding site, or rather discrete pockets of the protein surface. To test if small and chemically diverse Bcl-xL inhibitors are likely to bind a single pocket, and to identify which pocket, we used a battery of computational and modeling approaches. We first checked that the large dataset of Bcl-xL inhibitors we built can actually fit to a universal pharmacophore. Then we defined the probable binding hot spots of interaction through comparison of crystal structures, as well as virtual fragment screening. Finally, new analogues of small polyphenol derivatives were synthesized to precisely probe a hydrogen bond suggested by docking experiments. Bcl-xL inhibition potency of these products confirmed the predicted binding mode. This combination of X-ray structure exploration, molecular modeling studies and medicinal chemistry supports that al...Continue Reading

References

Jan 20, 1995·Science·T Clackson, J A Wells
Sep 9, 2004·Science·Loren D WalenskyStanley J Korsmeyer
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maryla KrajewskaJohn C Reed
Jul 3, 2007·Journal of Medicinal Chemistry·Susanne Eyrisch, Volkhard Helms
Jun 4, 2013·Trends in Pharmacological Sciences·Andrei A IvanovHaian Fu
Aug 27, 2013·Molecular Cancer Therapeutics·Christian Billard

❮ Previous
Next ❯

Citations

Mar 10, 2016·Chemico-biological Interactions·Nour H AboalhaijaMutasem O Taha
Jul 15, 2017·Current Medicinal Chemistry·Jelica VucicevicJohn B O Mitchell

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.